【结 构 式】 |
【分子编号】41073 【品名】(3S)-3-benzyl-4-(benzyloxy)-4-oxobutyric acid 【CA登记号】 |
【 分 子 式 】C18H18O4 【 分 子 量 】298.33852 【元素组成】C 72.47% H 6.08% O 21.45% |
与该中间体有关的原料药合成路线共 1 条
合成路线1
该中间体在本合成路线中的序号:(XXIII)The reaction of 2(S)-benzylsuccinic acid 1-benzyl monoester (XXIII) with cis-perhydroisoindole (V) by means of isobutyl chloroformate and NMM in THF gives the succinamic ester (XXIV), which is hydrogenated with H2 over Pd/C in ethanol, yielding the already described succinamic acid (XIII). Finally, this compound is converted into its calcium salt.
【1】 Castaner, R.M.; Sorbera, L.A.; Leeson, P.A.; Castaner, J.; Mitiglinide Calcium Hydrate. Drugs Fut 2000, 25, 10, 1034. |
【2】 Sato, F.; Tsubaki, A.; Hokari, H.; Tanaka, N.; Saito, M.; Akahane, K.; Kobayashi, M. (Kissei Pharmaceutical Co., Ltd.); Succinic acid cpds.. EP 0507534; JP 1992330055; JP 1992356459; JP 1993230019; US 5202335 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(V) | 41059 | (3aR,7aS)octahydro-1H-isoindole | C8H15N | 详情 | 详情 | |
(XIII) | 41064 | (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutyric acid | C19H25NO3 | 详情 | 详情 | |
(XXIII) | 41073 | (3S)-3-benzyl-4-(benzyloxy)-4-oxobutyric acid | C18H18O4 | 详情 | 详情 | |
(XXIV) | 41074 | benzyl (2S)-4-[(3aR,7aS)octahydro-2H-isoindol-2-yl]-2-benzyl-4-oxobutanoate | C26H31NO3 | 详情 | 详情 |
Extended Information